Logo image
Back
Contribution of health care coverage in cervical cancer screening follow-up: findings from a cross-sectional study in Colombia
Journal article   Open access   Peer reviewed

Contribution of health care coverage in cervical cancer screening follow-up: findings from a cross-sectional study in Colombia

Isabel C Garcés-Palacio, Maja Altarac, Russell Kirby, Leslie A McClure, Beverly Mulvihill and Isabel C Scarinci
International journal of gynecological cancer, v 20(7), pp 1232-1239
Oct 2010
DOI: https://doi.org/10.1111/IGC.0b013e3181e8dfb8
PMID: 21495237
Featured in Collection :   UN Sustainable Development Goals @ Drexel
url
https://doi.org/10.1111/igc.0b013e3181e8dfb8View
Published, Version of Record (VoR)CC BY-NC-ND V4.0,  Open

Abstract

Colombia - epidemiology Prognosis Uterine Cervical Neoplasms - diagnosis Cross-Sectional Studies Follow-Up Studies Early Detection of Cancer Papanicolaou Test Humans Middle Aged Uterine Cervical Neoplasms - epidemiology Continuity of Patient Care Uterine Cervical Neoplasms - prevention & control Cervical Intraepithelial Neoplasia - diagnosis Survival Rate Vaginal Smears Insurance Coverage Young Adult Delivery of Health Care Adolescent Cervical Intraepithelial Neoplasia - prevention & control Adult Female Cervical Intraepithelial Neoplasia - epidemiology
To determine the role of health care coverage (HCC) in follow-up of cervical cancer screening (seeking Papanicolaou test results and follow-up when abnormal results were found) among Colombian women. A population-based cross-sectional study of 24,717 women, using the 2005 Colombian Demographic and Health Survey, was conducted. Nearly 4% of women screened did not seek their results. For approximately 17% of the women, there was no follow-up when abnormal results were found. Women in the contributory regime (private insurance) and those in the subsidized regime (public insurance) were more likely to seek Papanicolaou test results than women without HCC, even after adjusting for sociodemographic factors (adjusted odds ratio [ORa], 1.96; 95% confidence interval [CI], 1.60-2.41 and ORa, 1.34; 95% CI, 1.14-1.58, respectively). For follow-up when abnormal results were found, there was no difference between the subsidized regime and no HCC, but women in the contributory regime were more likely to follow-up than women without HCC (ORa, 1.40; 95% CI, 1.05-1.86). Seeking Papanicolaou test results is relatively high among Colombian women; however, there are differences according to HCC. Follow-up when abnormal Papanicolaou test results were found was positively associated only with private insurance; follow-up is the same for women without insurance and with public insurance. Exploring strategies to promote follow-up among women and to improve cervical cancer follow-up services for those enrolled in the subsidized regime may increase follow-up rates among Colombian women.

Metrics

4 Record Views
9 citations in Web of Science
11 citations in Scopus

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#3 Good Health and Well-Being
#5 Gender Equality

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Collaboration types
Domestic collaboration
Web of Science research areas
Obstetrics & Gynecology
Oncology
Logo image